Sanofi joins VCs in backing new genomics start-up with up to $125m
This article was originally published in Scrip
Executive Summary
Sanofi is co-investing in a biotechnology start-up company, Warp Drive Bio, alongside two venture capital firms, Third Rock Ventures and Greylock Partners.